NCIt definition : A preparation of autologous T-lymphocytes that have been genetically engineered to
express a T-cell receptor (TCR) specific for the tumor-associated antigen (TAA) Kita-Kyushu
lung cancer antigen-1 (KK-LC-1), with potential immunomodulating and antineoplastic
activities. Upon administration, the autologous anti-KK-LC-1 TCR-expressing T-cells
specifically target and bind to KK-LC-1-expressing tumor cells. This leads to T-cell
activation and T-cell mediated lysis of KK-LC-1-expressing tumor cells. KK-LC-1, a
cancer germline (CG) antigen, is expressed in a variety of epithelial cancers and
has restricted expression in normal tissues.;